03309 C-MER MEDICAL
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.56X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 16.3% | Net Margin | N/A |
Total Debt/Equity | 23.8% | Return on Equity | N/A |
Price/Book | 1.26X | Return on Assets | N/A |
(HKD 1.760) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -135.16 | 62.00 | -21.88 | 21.86 | -6.25 |
---|---|---|---|---|---|
Net Profit Growth (%) | -318.0 | +383.4 | -200.1 | +450.0 | -115.1 |
Earnings Per Share (HKD) | -0.11 | 0.049 | -0.018 | 0.019 | -0.006 |
Earnings Per Share Growth (%) | -321.9 | +379.1 | -193.2 | +433.3 | -114.4 |
Dividend Per Share (HKD) | 0.020 | No dividend | No dividend | No dividend | 0.020 |
P/E* (X) | N/A | 35.63 | N/A | 92.63 | N/A |
Yield (%) | 1.14 | N/A | N/A | N/A | 1.14 |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 1.396 | 1.470 | 1.473 | 1.157 | 1.128 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 1,913 | 1,924 | -0.6 | 1,732 |
Operating Result | -73.817 | 121.226 | -160.9 | -48.601 |
Associates | -0.975 | 3.164 | -130.8 | 37.799 |
Profit Before Taxation | -76.221 | 124.269 | -161.3 | -11.227 |
Taxation | 32.093 | 37.934 | -15.4 | 34.998 |
Profit /( Loss) After Taxation | -108.314 | 86.335 | -225.5 | -46.225 |
Minority Interests | 26.849 | 24.337 | +10.3 | -24.35 |
Net Profit | -135.163 | 61.998 | -318.0 | -21.875 |
Earnings Per Share () | -0.1096 | 0.0494 | -321.9 | -0.0177 |
Dividend Per Share () | 0.0200 | 0.0000 | N/A | 0.0000 |
Announcement Date | 2025-03-21 | 2024-03-26 | NA | 2023-03-31 |
* Annualised
Last Update Time: 2025-07-22 21:40:25